- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01924117
Genotypification and Predisposing Factors in Human Papilloma Virus Infection (HPV)
Genotypification and Predisposing Factors in Human Papilloma Virus Infection and Its Association With the Carbohydrate Antigen (CA-125) Tumoral Marker
Objective: Determine the genotypes and risk factors associated with human papilloma virus infection in Mexican women.
Methods: It was a cross-sectional study of women attended at the Materno-Perinatal Hospital "Mónica Pretelini" and the Medical Research Center (CICMED), who were asked to complete a risk factor questionnaire and submitted to colposcopy to identify SIL. Cervical swab samples were obtained to perform linear array HPV genotyping test (Roche®, Mannheim, Germany).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Principles: The aim of this study was to determine the HPV genotypes in squamous intraepithelial lesions (SIL) in a population sample of the State of Mexico.
Patients:
The inclusion criteria were women submitted to a colposcopy study at the Clinic 221 of the Mexican Social Security Institute (IMSS), Maternal-Perinatal Hospital "Monica Pretelini" (HMPMP), State of Mexico Health Institute (ISEM) and the Medical Research Center (CICMED), Autonomous University of State of México (UAEMex). Women with previous conization were not considered into the study and those whose clinical follow up was lost were excluded.
Sociodemographic factors:
Patients were given a questionnaire to measure the following potential risk factors: age, area of residence, education level, sexual partners, participation in anal sex, age at first intercourse, smoking, use of hormonal contraception, use of condoms, number of pregnancies and vaginal deliveries.
Cervical samples:
Samples were collected by cervical scraping and were preserved in ThinPrep® PreservCyt® Solution (HologicTM Marlborough, Massachusetts, USA).
HPV genotyping:
DNA extraction from the cervical swab samples was performed using the Amplicor kit (Roche®, Mannheim, Germany), isolating simultaneously the β-globin gene along with HPV. HPV positive specimens were subsequently genotyped using the Linear Array HPV Genotyping assay (Roche®, Mannheim, Germany). This test is a qualitative in vitro test for the detection of HPV utilizing amplification of target DNA by the Polymerase Chain Reaction (PCR) and nucleic acid hybridization able to detect 37 anogenital HPV DNA genotypes (6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 64, 66, 67, 68, 69, 70, 71, 72, 73 (MM9), 81, 82 (MM4), 83 (MM7), 84 (MM8), IS39 and CP6108). This technique can detect multiple HPV genotypes in the same sample.
Ethical concerns:
We followed the Declaration of Helsinki and all patients were asked to sign the written informed consent. This study was accepted by the Research and Ethical Committee of the CICMED.
Statistical analysis:
First, descriptive analyzes were performed, secondly, Odds Ratios (OR) and their associated 95% confidence intervals (95% CI) were calculated as well as Chi-square tests and conditional regression model for SIL using the Statistical Package for the Social Sciences (SPSS) 17.0 software. Difference was considered significant at p ≤ 0.05.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Sexually active women 18 to 40 years of age who come to consult the dysplasia clinic.
- Who are not pregnant
- Who have not received pharmacological treatment with antibiotics and / or anti-inflammatory drugs at least one month before the study.
- Who agreed to participate in the study and signed the informed consent letter.
- Acceptance to fill the questionnaire with relevant data related to HPV risk infection
Exclusion Criteria:
- Inadequate samples
- Questionnaires with incomplete data
- Women who decided to leave the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Linear Array HPV Genotyping assay
Women submitted to colposcopy with a suspicion of squamous intraepithelial lesion were programmed a clinical follow up to cervical swab in order to extract DNA and perform a Linear Array HPV Genotyping assay (Roche®, Mannheim, Germany).
|
All samples with the suspicion of squamous intraepithelial lesion were processed with the Linnear Array methodology to identify HPV genotypes
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Multiple HPV infection
Time Frame: At the moment of the colposcopy
|
While women are revised by colposcopy the Gynecologist will refer them to a cervical swab for DNA extraction in case of suspicious of HPV infection.
|
At the moment of the colposcopy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
squamous intraepithelial lesions
Time Frame: Within one week after the cervical sample taken by the technician
|
The pathologist will determine the presence or absence of SIL with the sample taken in the Papanicolaou smear appointment
|
Within one week after the cervical sample taken by the technician
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Hugo Mendieta Zerón, PhD., Universidad Autonoma del Estado de Mexico
- Principal Investigator: María del Carmen Colín Ferreyra, MSc., Universidad Autonoma del Estado de Mexico
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2902/2010UAEMéx
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraepithelial Neoplasia
-
Krankenhaus Barmherzige Schwestern LinzMedical University of ViennaCompletedCervical Intraepithelial Neoplasia Grade 1 | Cervical Intraepithelial Neoplasia Grade 2Austria
-
Coordinación de Investigación en Salud, MexicoUniversity of Guadalajara; Instituto Mexicano del Seguro SocialCompletedConjunctival Intraepithelial Neoplasia | Corneal Intraepithelial NeoplasiaMexico
-
Genexine, Inc.CompletedCervical Intraepithelial Neoplasia 3Korea, Republic of
-
Nykode Therapeutics ASATheradex; Vaccibody ASCompletedHigh Grade Cervical Intraepithelial NeoplasiaGermany
-
University of Alabama at BirminghamNational Cancer Institute (NCI)CompletedHigh-grade Cervical Intraepithelial NeoplasiaUnited States
-
ViMREX GmbHFrankfurter Institut für Klinische Krebsforschung IKF GmbH am Krankenhaus...Active, not recruitingVulvar Intraepithelial Neoplasia Grade 2 | Vulvar Intraepithelial Neoplasia Grade 3Germany
-
BioLeaders CorporationUnknownCervical Intraepithelial Neoplasia Grade 2/3Korea, Republic of
-
University Medical Centre MariborRecruitingCervical Intraepithelial Neoplasia Grade 2 | DNA MethylationSlovenia
-
National Cancer Institute (NCI)TerminatedCervical Cancer | Cervical Intraepithelial Neoplasia Grade 2 | Cervical Intraepithelial Neoplasia Grade 3United States
-
Jun ZhangXiamen Innovax Biotech Co., Ltd; Beijing Wantai Biological Pharmacy Enterprise...RecruitingCervical Cancer | Cervical Intraepithelial Neoplasia | Vaginal Intraepithelial Neoplasia | Vulvar Intraepithelial Neoplasia | Persistent InfectionChina
Clinical Trials on Linear Array HPV Genotyping assay
-
Becton, Dickinson and CompanyActive, not recruiting
-
Karolinska University HospitalActive, not recruiting
-
Universitaire Ziekenhuizen KU LeuvenSciensanoTerminatedHuman Immunodeficiency VirusBelgium
-
Chulalongkorn UniversityCompletedPterygium | Human Papilloma Virus InfectionThailand
-
BioMérieuxBioFortis; APHPUnknownRespiratory Tract InfectionsFrance
-
Chang Gung Memorial HospitalDr. Chip Biotechnology IncorporationCompletedCervical Intraepithelial Neoplasia | HPV Infection | Human Papillomavirus InfectionTaiwan
-
Gen-Probe, IncorporatedCompletedHuman Papillomavirus InfectionUnited States
-
Gen-Probe, IncorporatedCompletedHuman Papillomavirus InfectionUnited States
-
Queen Mary University of LondonNational Cancer Institute (NCI)Recruiting